Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TiCAB: Ticagrelor in CABG
NCT01755520Phase 3Terminated
- Sponsor
- Deutsches Herzzentrum München
- Start
- Apr 2013
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of ticagrelor in coronary artery disease (CAD), stable angina, acute coronary syndrome (ACS), sponsored by Deutsches Herzzentrum München. Started Apr 2013; status: terminated.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)stable anginaacute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01755520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755520.